Markets:

Overview

News

Currencies

International

Treasuries

Aptevo Therapeutics Inc. - Common Stock (NQ:APVO)

8.000 -0.320 (-3.85%)

Streaming Delayed Price Updated: 10:33 AM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aptevo Therapeutics Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Aptevo Therapeutics: Q2 Earnings Insights ↗

August 11, 2022

Aptevo Therapeutics (NASDAQ:APVO) reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Aptevo Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights

August 11, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 23, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 10, 2022

Via Benzinga

Aptevo Therapeutics Announces New Preliminary Remission Data on Four Additional Patients Enrolled in On-going APVO436 Dose Expansion Phase 1b Trial for the Treatment of Acute Myeloid Leukemia

June 09, 2022

Cohort 1 Combination Therapy Arm Shows 36% Remission Rate Among Response-evaluable Patients Treated to Date

From Aptevo Therapeutics

Via AccessWire

Recap: Aptevo Therapeutics Q1 Earnings ↗

May 12, 2022

Aptevo Therapeutics (NASDAQ:APVO) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Are Aptevo Therapeutics Shares Trading Higher Today? ↗

February 09, 2022

Aptevo Therapeutics Inc (NASDAQ: APVO)

Via Benzinga

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

Aptevo Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights

May 12, 2022

SEATTLE, WA / ACCESSWIRE / May 12, 2022 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology...

From Aptevo Therapeutics

Via AccessWire

APVO442 Prostate Cancer Data Presented at the American Association for Cancer Research Annual Meeting

April 12, 2022

Preclinical Data Support Potential for APVO442 in Difficult-to-Treat Types of Prostate Cancer, Including Metastatic Castration-Resistant Disease SEATTLE, WA / ACCESSWIRE / April 12, 2022 / Aptevo...

From Aptevo Therapeutics

Via AccessWire

Aptevo Therapeutics Announces Monotherapy Patient Received a Transplant in APVO436 Expansion Trial for the Treatment of Acute Myeloid Leukemia

March 29, 2022

Patients in Both Monotherapy and Combination Arms in Multi-Cohort Trial Have Achieved Transplant Eligible Status SEATTLE, WA / ACCESSWIRE / March 29, 2022 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a...

From Aptevo Therapeutics

Via AccessWire

Aptevo Therapeutics Earnings Perspective: Return On Capital Employed ↗

March 25, 2022

According to Benzinga Pro data, during Q4, Aptevo Therapeutics (NASDAQ:APVO) posted sales of $3.67 million. Earnings were up 10.36%, but Aptevo Therapeutics still reported an...

Via Benzinga

63 Biggest Movers From Yesterday ↗

March 25, 2022

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Rises 150 Points; Emclaire Financial Shares Spike Higher ↗

March 24, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq composite gaining over 150 points on Thursday. The Dow traded up 0.76% to 34,621.33 while the NASDAQ rose 1.19...

Via Benzinga

Why Did Aptevo Therapeutics Stock Jump 25% Today? ↗

March 24, 2022

Aptevo Therapeutics Inc (NASDAQ: APVO) shares are trading higher Thursday after the company reported 2021 financial results. Aptevo said royalty revenue totaled $...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 24, 2022

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) stock increased by 26.3% to $1.73 during Thursday's regular session. The current volume of 55.2 million shares is 5751.8...

Via Benzinga

Mid-Day Market Update: Dow Surges 250 Points; LiqTech International Shares Slide ↗

March 24, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones jumping 250 points on Thursday. The Dow traded up 0.75% to 34,617.38 while the NASDAQ rose 1.08% to 14,072.31...

Via Benzinga

34 Stocks Moving In Thursday's Mid-Day Session ↗

March 24, 2022

Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 37.7% to $4.64. Emclaire Financial Corp (NASDAQ: EMCF) shares climbed 32.8% to $38.35 after the company and...

Via Benzinga

Aptevo Therapeutics: Q4 Earnings Insights ↗

March 24, 2022

Aptevo Therapeutics (NASDAQ:APVO) reported its Q4 earnings results on Thursday, March 24, 2022 at 08:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Aptevo Therapeutics Reports 2021 Financial Results and Provides Business Update

March 24, 2022

SEATTLE, WA / ACCESSWIRE / March 24, 2022 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its...

From Aptevo Therapeutics

Via AccessWire

60 Biggest Movers From Yesterday ↗

February 10, 2022

Gainers US Ecology, Inc. (NASDAQ: ECOL) shares surged 67.7% to close at $47.25 on Wednesday after Republic Services reported it will buy the company at $48 per share in cash....

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

February 09, 2022

Gainers US Ecology, Inc. (NASDAQ: ECOL) shares jumped 68.1% to $47.34 after Republic Services reported it will buy the company at $48 per share in cash. Tritium DCFC Limited (...

Via Benzinga

Aptevo Therapeutics Earns $10 Million Non-Dilutive Milestone Payment on Sales of RUXIENCE, Provides Company Update

February 09, 2022

APVO436 Phase 1b Trial for Acute Myeloid Leukemia Adds New Site Complete Remission Patient to Advance to Transplant SEATTLE, WA / ACCESSWIRE / February 9, 2022 / Aptevo Therapeutics Inc. ("Aptevo" or...

From Aptevo Therapeutics

Via AccessWire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 24, 2022

Gainers Aptorum Group (NASDAQ:APM) stock m...

Via Benzinga

Aptevo Therapeutics' Board Chairman, Fuad El-Hibri, Announces Retirement, Effective April 1, 2022

January 21, 2022

Vice Chairman, John E. Niederhuber, M.D., to Assume Chairmanship, Effective April 1, 2022 SEATTLE, WA / ACCESSWIRE / January 21, 2022 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company")...

From Aptevo Therapeutics

Via AccessWire

Topics Retirement

Alligator Bioscience & Aptevo Therapeutics Announce Co-Publication in Peer-Reviewed Journal, "Nature Communication"

December 15, 2021

LUND, SWEDEN and SEATTLE, WA / ACCESSWIRE / December 15, 2021 / Alligator Bioscience AB ("Alligator") and Aptevo Therapeutics ("Aptevo") (NASDAQ:APVO) today announced publication of an article in the...

From Aptevo Therapeutics

Via AccessWire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

December 13, 2021

Welcome back, investor! With our return from the weekend comes a dive into the biggest pre-market stock movers for Monday!

Via InvestorPlace

22 Stocks Moving in Monday's Pre-Market Session ↗

December 13, 2021

Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 32.6% to $3.58 in pre-market trading after gaining more than 14% on Friday. Foghorn Therapeutics Inc. (NASDAQ: FHTX) rose...

Via Benzinga

61 Biggest Movers From Yesterday ↗

December 02, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down...

Via Benzinga

Topics Intellectual Property

50 Stocks Moving In Wednesday's Mid-Day Session ↗

December 01, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's...

Via Benzinga

Topics Intellectual Property

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.